xTAG GPP offers the ability to non-invasively analyze patient stool samples for 14 GI pathogen targets simultaneously and at a much quicker processing time, as compared with conventional industry testing methods.
- Superior sensitivity and specificity for detection of the most common enteric pathogens.
- Faster diagnosis of gastrointestinal infections with fewer tests and reduced costs.
- Co-infections determined by one multi-pathogen panel versus multiple tests.
Same Day Results for 14 of the Most Common Causes of Infectious Diarrhea
Improve patient outcomes, avoid needless isolation costs, and act fast to prevent outbreak situations with xTAG® GPP.
From a single and simple laboratory test, you can get results for 14 of the most common causes of infectious gastroenteritis from a single stool sample in less than 5 hours. xTAG GPP is a qualitative multiplex test intended for the simultaneous detection and identification of nucleic acids from multiple gastroenteritis-causing viruses, bacteria and parasites (including toxin gene detection) in human stool samples.
This panel will replace traditional stool culture (STOCU) and the Giardia and Cryptosporidium antigen (OVPSC) screen.
Polymerase chain reaction (PCR)
Same day (within 12 to 18 hours of receiving specimen), Monday through Friday
Collect : Small amount of fecal material - 2 g. or 2 mL liquid stool.
Specimen preparation: Place into screw top Sterile Container. Storage/Transport Temperature: Refrigerated
Keywords: Gastrointestinal Pathogen Panel, xTAG®, Gastrointestinal Pathogen Panel, GPP, PCR, Gastroenteritis, Gastrointestinal viruses, Gastrointestinal bacteria, xTAG GPP, Acute diarrhoea illness, Campylobacter, Clostridium difficile Toxin A/B, Cryptosporidium, E. coli, Enterotoxigenic E.coli (ETEC), Shiga Toxin-producing E. coli (STEC), Giardia lamblia, Norovirus GI/GII, Rotavirus A, Salmonella, Shigella, GI PanelTest, GIP, GI Health Panel, Luminex GI Panel, GI Panel PCR, GI Panel Lab Test, GI Pathogen Screen, New-York, Los Angeles; Chicago; Houston; Philadelphia; Phoenix; San Antonio; San Diego; Dallas; San Jose; Austin; Jacksonville; Indianapolis; San Francisco; Columbus; Fort Worth; Charlotte; Detroit; El Paso; Memphis; Boston; Seattle; Denver; Washington; Nashville-Davidson; Baltimore; Louisville, Jefferson; Portland; Oklahoma ; Milwaukee; Las Vegas; Albuquerque; Tucson; Fresno; Sacramento; Long Beach; Kansas ; Mesa; Virginia Beach; Atlanta; Colorado Springs; Raleigh; Omaha; Miami; Oakland; Tulsa; Minneapolis; Cleveland; Wichita; Arlington; New Orleans; Bakersfield; Tampa; Honolulu; Anaheim; Aurora; Santa Ana; St. Louis; Riverside; Corpus Christi; Pittsburgh; Lexington-Fayette; Anchorage municipality, Stockton; Cincinnati; St. Paul; Toledo; Newark; Greensboro; Plano; Henderson; Lincoln; Buffalo; Fort Wayne; Jersey City; Chula Vista; Orlando; St. Petersburg; Norfolk; Chandler; Laredo; Madison; Durham; Lubbock; Winston-Salem; Garland; Glendale; Hialeah; Reno;Baton Rouge; Irvine; California Chesapeake; Irving; Scottsdale; North Las Vegas; Fremont; Gilbert town, San Bernardino; Boise; Birmingham; Brooklyn
The xTAG® Gastrointestinal Pathogen Panel (GPP) is a multiplexed nucleic acid test intended for the simultaneous qualitative detection and identification of multiple viral, parasitic, and bacterial nucleic acids in human stool specimens from individuals with signs and symptoms of infectious colitis or gastroenteritis.
The detection and identification of specific gastrointestinal microbial nucleic acid from individuals exhibiting signs and symptoms of gastrointestinal infection aids in the diagnosis of gastrointestinal infection when used in conjunction with clinical evaluation, laboratory findings, and epidemiological information. A gastrointestinal microorganism multiplex nucleic acid-based assay also aids in the detection and identification of acute gastroenteritis in the context of outbreaks. xTAG GPP positive results are presumptive and must be confirmed by FDA-cleared tests or other acceptable reference methods.¹ The GPP PCR is the first FDA cleared diagnostic to offer detection of 11 major GI pathogens and rule out over 90% of agents that cause diarrhea in a single test. The method screens for bacteria, viruses and parasites in one test, in one lab location with much faster turn around time.
Testing should be performed on individuals exhibiting signs and symptoms of gastrointestinal infection and to aid in the diagnosis of gastrointestinal infection when used in conjunction with clinical evaluation, laboratory findings, and epidemiological information. A gastrointestinal microorganism multiplex nucleic acid-based assay also aids in the detection and identification of acute gastroenteritis in the context of outbreaks (1).
xTAG GPP simultaneously detects 14 common viral, bacterial, and parasitic causative pathogens from a single patient sample:
• Clostridium difficile toxin A/B
• Escherichia coli (E. coli) O157
• Enterotoxigenic E. coli (ETEC) LT/ST
• Shiga-like Toxin producing E. coli (STEC) stx 1/stx 2
• Vibrio cholerae, cholera toxin gene (ctx)
• Adenovirus 40/41
• Rotavirus A
• Entamoeba histolytica
This test is not recommended for in-patients hospitalized for more than 3 days.
The target is amplified using polymerase chain reaction (PCR) or reverse transcription PCR, then analyzed with Luminex xTAG technology to detect the presence or absence of each pathogen in the panel. The test has been cleared or approved for diagnostic use by the U.S. Food and Drug Administration for fecal specimens.
The Gastrointestinal Pathogen Panel (GPP) is a multiplexed nucleic acid test intended for the simultaneous qualitative detection and identification of multiple viral, parasitic, and bacterial nucleic acids from stool specimens from individuals with signs and symptoms of infectious colitis or gastroenteritis.
Information derived from Gastrointestinal Pathogen Panel Package Insert (Luminex Corporation). Gastrointestinal Pathogen Panel is a product of Luminex Corporation. xTAG is a registered trademark of Luminex Corporation. Luminex is a registered trademark of Luminex Corporation.
USING GPP IN YOUR CLINICAL PRACTICE
• Non-invasive stool test
• Outstanding accuracy
• Helps decrease and contain outbreaks of highly contagious gastrointestinal infections
• Turn-around time of just 24 hours!
• Helps reduce over-prescription of antibiotics
• Provide better patient care
• Patients return specimens to th lab directly via FedEX
• Widely covered by major insurances
When should the testing be ordered?
• Persistent or chronic diarrhea
• Bloody diarrhea
• Diarrhea in association with systemic illness
• Immunocompromised status
• Returned traveler
• Hospitalized patient
• Outbreak identification
In healthcare settings and in specific populations (newborns/infants, elderly or immunocompromised patients), these infections are potentially serious. Rapid diagnosis is important for appropriate treatment and infection control measures.
Luminex xTAG GPP Gastrointestinal Pathogen Panel
How to get Gastrointestinal Pathogen Panel (GPP)
Register your contact details and set up an account with us.